Form 4 for PFE Pfizer
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001225208-22-003666 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-01 | 2022-02-26 | PFE | McDermott Michael | EVP | M - OptEx | $25.60 | +12.3K | 83.5K | +17% | +$315.9K |
| DM | 2022-03-01 | 2022-02-26+ | PFE | McDermott Michael | EVP | F - Tax | $49.37 | -9,517 | 81.2K | -10% | -$469.9K |
| D | 2022-03-01 | 2022-02-26 | PFE | McDermott Michael | EVP | M - OptEx | $0.00 | -12.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-26 | M | A | 12,340 | $25.60 | 83,530 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 2 | Common | Common Stock | 2022-02-26 | F | D | 5,761 | $50.64 | 75,397 | D | — | — | (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 3 | Common | Common Stock | 2022-02-28 | F | D | 1,384 | $46.94 | 74,013 | D | — | — | (F6) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| 4 | Common | Common Stock | 2022-02-26 | F | D | 2,372 | $47.72 | 81,158 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 25, 2022. |
| 5 | Derivative | Stock Appreciation Rights | 2022-02-26 | M | D | 12,340 | $0.00 | 0 | D | $25.60 · 2022-02-26 to 2022-02-26 | 12,340 Common Stock |